|
|||||||||
| Welcome Guest |  |
 |
Register Now! |
Bristol Laboratories Ltd- UK
The diverse range of products manufactured by Bristol Laboratories is a testimony to its commitment to make a positive contribution to the healthcare system. Scientists at Bristol Laboratories are constantly evaluating the feasibility of products designed to reduce the cost of manufacturing, while retaining the safety and efficacy of the product molecule. There is a constant endeavour to formulate newer generics and make them available to the health care providers.
From the active ingredient to the final finished dosage form, our quality driven value system ensures that the product made available to the consumer is of the highest standard of quality and efficacy.
Bristol Laboratories is gearing up to play an important role in the world generic market. It has a diverse product portfolio of 54 molecules offering over 167 presentations, with many more in the pipeline.
Additional 20 molecules have been developed and are under various stages of dossier compilation and registration.
This is expected to add another 60 presentations to the current product line over the next couple of years Bristol Laboratories extensive range of products cover the following therapeutic classes:
The diverse range of products manufactured by Bristol Laboratories is a testimony to its commitment to make a positive contribution to the healthcare system. Scientists at Bristol Laboratories are constantly evaluating the feasibility of products designed to reduce the cost of manufacturing, while retaining the safety and efficacy of the product molecule. There is a constant endeavour to formulate newer generics and make them available to the health care providers.
From the active ingredient to the final finished dosage form, our quality driven value system ensures that the product made available to the consumer is of the highest standard of quality and efficacy.
Bristol Laboratories is gearing up to play an important role in the world generic market. It has a diverse product portfolio of 54 molecules offering over 167 presentations, with many more in the pipeline.
Additional 20 molecules have been developed and are under various stages of dossier compilation and registration.
This is expected to add another 60 presentations to the current product line over the next couple of years Bristol Laboratories extensive range of products cover the following therapeutic classes:
| Products by therapeutic area |
| Search By Alphabetic Category »»»All | A-D | E-H | I-N | O-R | S-Z |
| Product Name | Strength | Presentation | Dosage form |
| Allopurinol | 100 mg | 28's | Tablets | 300 mg | 28's | Tablets |
| Amlodipine Besilate | 5 mg | 28’s | Tablets | 10 mg | 28’s | Tablets |
| Amoxicillin | 125 / 5 mg / ml | 100ml | Powder for Oral suspension | 125 / 5 mg / ml | 100ml | Sugar Free Powder for Oral suspension | 250 mg | 21’s | Capsules | 250 mg | 250’s | Capsules | 250 / 5 mg / ml | 100ml | Powder for Oral suspension | 250 / 5 mg / ml | 100ml | Sugar Free Powder for oral suspension | 500 mg | 21’s | Capsules | 500 mg | 100’s | Capsules |
| Aspirin | 75 mg | 28’s | Dispersible tablet | 75 mg | 28’s | Enteric coated tablets | 75 mg | 56’s | Enteric coated tablets | 300 mg | 16’s | Tablets | 300 mg | 32’s | Tablets |
| Atenolol | 25 mg | 28’s | Tablets | 50 mg | 28’s | Tablets | 100 mg | 28’s | Tablets |
| Bendroflumethiazide | 2.5 mg | 28’s | Tablets | 5 mg | 28’s | Tablets |
| Captopril | 12.5 mg | 56’s | Tablets | 25mg | 56's | Tablets | 50 mg | 56’s | Tablets |
| Carvedilol | 3.125 mg | 28’s | Tablets | 6.25 mg | 28’s | Tablets | 12.5 mg | 28’s | Tablets | 25 mg | 28’s | Tablets |
| Cetirizine Hydrochloride | 10 mg | 30s | Tablets |
| Ciprofloxacin | 100 mg | 6’s | Tablets | 250 mg | 10’s | Tablets | 500 mg | 10’s | Tablets | 750 mg | 10’s | Tablets |
User Login
Alliances